Primary Health Properties offers £1.5bn to merge with Assura
Real estate investment group Primary Health Properties has made a £1.5bn proposal to merge with Assura, the developer and manager of GP and primary care buildings.
Under the cash and shares proposal, Assura shareholders will receive 0.3848 new PHP shares and 9.08p in cash, implying a value of 46.2p per Assura share - a 23.5% premium to its closing share price on the day before the offer period commenced on 13 February.
If the proposed merger goes ahead, Assura shareholders would hold 48% of the combined group's issued share capital.
PHP said that a deal would deliver "significant strategic and financial benefits" for shareholders on both side, creating the eighth largest UK-listed real estate investment trust, with a £6bn portfolio of long-leased, sustainable infrastructure assets.
The company also predicts there would be notable cost and operating synergies, bolstering earnings accretion and dividend growth for both companies, as well as improved access to capital markets.
The proposal comes ahead of the 'put up or shut up' deadline on 7 April.
"PHP is announcing the possible terms of the combination to provide shareholders of both companies with the opportunity to make their views known regarding the attractiveness of the combination, and to urge Assura shareholders to encourage the board of Assura to provide PHP with an extension to the deadline," PHP said in a statement.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.